Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Walgreens starts strategic review for UK-based Boots business

Published 01/11/2022, 04:46 PM
Updated 01/11/2022, 04:51 PM
© Reuters. FILE PHOTO: A logo of the British chemist chain, Boots, is seen in central London October 3, 2005.

© Reuters. FILE PHOTO: A logo of the British chemist chain, Boots, is seen in central London October 3, 2005.

(Reuters) - Walgreens Boots Alliance (NASDAQ:WBA) Inc has begun a strategic review of its U.K.-based Boots business, Chief Executive Officer Rosalind Brewer said on Tuesday, as the second largest U.S. pharmacy chain tries to renew its focus on U.S. healthcare.

The Boots business has over 2,200 stores across the UK, which include pharmacies, health and beauty stores, among others, according to the chain's website.

"This review is very much in line with our renewed priorities and strategic direction. In particular, our increased focus on U.S. healthcare. While the process is at an exploratory stage, we do expect to move quickly," Brewer said at the J.P Morgan Healthcare Conference.

The review comes at a time when the company, which was formed in 2014 after the acquisition of stake in Alliance Boots by Walgreens, moves beyond its drugstores with its investments in two smaller healthcare providers, CareCentrix and VillageMD.

© Reuters. FILE PHOTO: A logo of the British chemist chain, Boots, is seen in central London October 3, 2005.

Late last year, Walgreens also launched its Walgreens Health unit to provide pharmacy and primary care services in stores, at home, or at a doctor's office and via mobile app.

Boots UK comparable pharmacy sales increased 8.8% in the quarter ended November due to increased footfalls.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.